|
|
|
|
Adult Acute Myeloid Leukemia
Positive opinion for Bioenvision's leukemia drug Feb 24, 2006
Pharmaceutical Business Review Bioenvision's CEO. Bioenvision is also developing Evoltra for the treatment of adult acute myeloid leukemia (AML) as first-line therapy. The ...
Bioenvision Reports Second Quarter 2006 Financial Results Feb 14, 2006
Genetic Engineering News, ...with the increased clofarabine development activities and ongoing clinical trials for pediatric acute leukemia and adult acute myeloid leukemia in Europe. ...
Bioenvision's Clofarabine Receives a Positive Opinion from the ... Feb 23, 2006
Business Wire (press release), ...diagnosis.". Bioenvision is also developing Evoltra(TM) for the treatment of adult acute myeloid leukemia (AML) as first-line therapy. ...
SRI children's cancer drug clears hurdle Feb 25, 2006
Birmingham News, Bioenvision said it has completed enrolling subjects for its Phase II clinical trial on adult acute myeloid leukemia in elderly patients and expects to apply ...
Bioenvision's EU Blessing Removes 'Major Risk' Feb 23, 2006
Forbes ...drug. Bioenvision also said today it expects to file for European approval of Evoltra for adult acute myeloid leukemia in mid-2006. ...
More ill Field Lab workers may qualify for compensation Oct 20, 2005
Ventura County Star (subscription), ..."I'm hoping they are going to process my claim," the Woodland Hills resident said. In 2001, Perock was diagnosed with adult acute myeloid leukemia. ...
APL during Gefitinib Treatment for Non–Small-Cell Lung Cancer -- Feb 23, 2005
Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a ... / New England Journal of Medicine (subscription),
APL during Gefitinib Treatment for Non–Small-Cell Lung Cancer Feb 23, 2005
Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a ... New England Journal of Medicine (subscription)
Toddler takes big steps Jun 9, 2004
By ZHANDA MALONE. At 20 months, Ashley Haines has spent a majority of her life battling adult acute myeloid leukemia (AML). With ... Edwardsville Intelligencer, IL -
Insights into the Mechanisms of Pulmonary Hypertension? -- Oct 8, 2004
Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 2004;350:1605–1616. ... / AJRCCM (subscription),
[an error occurred while processing this directive]
Acute myelogenous leukemia (AML), also known as acute myeloid leukemia, is a cancer of the myeloid line of blood cells. It is the most commonly diagnosed type of adult leukemia, and is rare among children.
These malignant cells called myeloblasts fail to mature into the different types of blood cells, a process called differentiation. If differentiation does not occur, the myeloblasts accumulate and overtake the number of healthy blood cells, spreading into the bloodstream and other vital organs. The lack of healthy blood cells results in symptoms such as anaemia and abnormal bruising.
Myeloid leukemias are characterized as "acute" or "chronic" based on how quickly they progress if not treated. Chronic myelogenous leukemia (CML) is often without symptoms and can remain dormant for years before transforming into a blast crisis, which is markedly similar to AML.
|
|
|
